Related Experiment Video
Updated: Jul 15, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients
Giuseppe Boriani1, Niccolo' Bonini2, Marco Vitolo2
1Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo, 71, Modena 41124, Italy.
Insights
Asymptomatic atrial fibrillation (AF) poses a higher risk for adverse outcomes, specifically in patients with heart failure (HF) and reduced left ventricular ejection fraction (LVEF). This highlights the importance of considering AF symptom status in HF management.
Area of Science:
- Cardiology
- Clinical Medicine
- Epidemiology
Background:
- Atrial fibrillation (AF) management requires understanding outcomes in diverse patient subgroups.
- The prognostic implications of asymptomatic versus symptomatic AF in patients with heart failure (HF) and varying left ventricular ejection fraction (LVEF) remain unclear.
Purpose of the Study:
- To clarify the outcome differences between asymptomatic and symptomatic AF patients stratified by HF and LVEF status.
- To investigate the independent association of asymptomatic AF with adverse events in specific HF and LVEF subgroups.
Main Methods:
- Prospective observational study including 8096 AF patients.
- Patients categorized into 8 groups based on overt HF presence and LVEF (≤40% or >40%).
- Follow-up for composite outcomes (all-cause death, MACE) and analysis of asymptomatic vs. symptomatic AF impact.
Main Results:
- No significant difference in the composite outcome between asymptomatic and symptomatic AF across the entire cohort.
- Asymptomatic AF patients with HF and LVEF ≤40% showed significantly worse outcomes (composite outcome and all-cause death) compared to symptomatic AF patients in the same group.
- Adjusted analysis revealed asymptomatic AF with HF and LVEF ≤40% as an independent predictor of higher risk for composite outcomes and all-cause death.
Conclusions:
- In a large European AF cohort, asymptomatic AF did not increase overall 2-year composite outcome risk compared to symptomatic AF.
- However, asymptomatic AF is associated with adverse outcomes in patients with heart failure and reduced left ventricular ejection fraction (LVEF ≤40%).
Background:
The outcome implications of asymptomatic vs. symptomatic atrial fibrillation (AF) in specific groups of patients according to clinical heart failure (HF) and left ventricular ejection fraction (LVEF) need to be clarified.
Methods:
In a prospective observational study, patients were categorized according to overt HF with LVEF≤40 %, or with LVEF>40 %, or without overt HF with LVEF40 %≤ or > 40 %, as well as according to the presence of asymptomatic or symptomatic AF.
Results:
A total of 8096 patients, divided into 8 groups according to HF and LVEF, were included with similar proportions of asymptomatic AF (ranging from 43 to 48 %). After a median follow-up of 730 [699 -748] days, the composite outcome (all-cause death and MACE) was significantly worse for patients with asymptomatic AF associated with HF and reduced LVEF vs. symptomatic AF patients of the same group (p = 0.004). On adjusted Cox regression analysis, asymptomatic AF patients with HF and reduced LVEF were independently associated with a higher risk for the composite outcome (aHR 1.32, 95 % CI 1.04-1.69) and all-cause death (aHR 1.33, 95 % CI 1.02-1.73) compared to symptomatic AF patients with HF and reduced LVEF. Kaplan-Meier curves showed that HF-LVEF≤40 % asymptomatic patients had the highest cumulative incidence of all-cause death and MACE (p < 0.001 for both).
Conclusions:
In a large European cohort of AF patients, the risk of the composite outcome at 2 years was not different between asymptomatic and symptomatic AF in the whole cohort but adverse implications for poor outcomes were found for asymptomatic AF in HF with LVEF≤40 %.
More Related Videos
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations

